Virtual reality is often touted as the “next big thing” among tech companies. Goldman Sachs believes that the market could blossom into an $80 billion one by2025, and Facebook (NASDAQ:FB) CEO Mark Zuckerberg has repeatedly called VRa next-gen “computing platform.”
However, the aging bull market and hype regarding VR-related stocks have made it tough to find fundamentally....More>>>
UBS analyst Brennan Hawken and team explain why they initiated Wells Fargo (WFC) with a Sell rating today:
Andrew Harrer/Bloomberg News
We see risks to Wells Fargo’s revenue growth and credit performance, which coupled with a valuation on the high end of peers and consensus estimates that have not come down much, putsWells Fargo shares at risk of underperformance in our view.....More>>>
Intrexon (XON) has made a small yet strategic acquisition in buying GenVec (GNVC); with the purchase, XON gets AdenoVerse, a platform of adenovirus vectors for delivering drugs and vaccines that dovetails nicely with its existing suite of gene therapy technologies, suggests John McCamant, editor of The Medical Technology Stock Letter.
The ability to increase the payloads of viral vectors....More>>>
24/7 Wall St. has put together a preview of some of the major companies reporting their quarterly results this week. We are currently in between earnings seasons, but there are still a few major companies reporting in the meantime. We have included the consensus earnings estimates from Thomson Reuters and the stock price and trading history, as well as added some additional color on each.
Europes main stock benchmark finished with a small gain on Monday, with rises for commodities-related companies, French telecom SFR Group SA and Swiss software maker Temenos Group AG helping to lead the gauge higher.
Opiates are incredibly potent pain relievers forpatients with severe traumatic pain or dealing with end-of-life care, but they are also being increasingly abused. Robert Brooke, the CEO of small cap Vitality Biopharma, Inc. (OTCQB: VBIO), which is dedicated to the development of cannabinoid prodrug pharmaceuticals and to unlocking the power of cannabinoids for the treatment of serious neurological....More>>>
Boeing Co.’s (NYSE: BA) share price added less than half a point last week but it was not for lack of good news. With just a week to go in 2017, the aerospace giant is a sure thing to close out the year as the best performing stock among the 30 stocks that make up the Dow Jones Industrial
AT&T Inc. (NYSE:T) has been on fire, rallying over 15% since November 1. However, T stock price is still down more than 9% so far for 2017. So is it time to get in on this recent momentum or take a pass on the telecom giant?
U.S. equities melted higher again on Monday, pushing the Dow Jones Industrial Average to its 70th record close for the year (something it’s never done before) as price momentum pushes to its most overbought level since the 1950s.
There have been no down months since President Trump
With the Nasdaq breaching the 7,000 barrier one can safely say that this was a year when tech stocks really came into their own. To put things in perspective, the Technology Select Sector SPDR is up nearly 35% year to date, easily outperforming its closest peers by nearly 15%.
December 18, 2017: Markets opened higher again Monday now that passage of the corporate- and investor-friendly Republican tax bill appears headed for passage. A few merger/acquisitions were announced this morning with Campbell Soup’s deal for Snyder’s-Lance the biggest. Materials and